Doxy-Denk 100

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

doxycycline (doxycycline hyclate)

Available from:

Artesan Pharma GmbH & Co. KG

INN (International Name):

doxycycline (doxycycline hyclate)

Dosage:

100mg

Pharmaceutical form:

tablets

Prescription type:

Prescription

Patient Information leaflet

_Doxy-Denk 100_
Tablets – oral use
Antibiotic
Active ingredient: doxycycline
INSTRUCTIONS FOR USE
Please read carefully.
Read this entire leaflet carefully before
you start taking this medicine.
– Keep this package leaflet. You may like to read it again later.
– If you have further questions, please ask your doctor or your
pharmacist.
– This medicine has been prescribed for you personally and
should not be passed on to others. It may harm other people,
even if their symptoms are the same as yours.
ACTIVE INGREDIENTS
1 tablet contains 115.4 mg doxycycline hyclate, equivalent to 100 mg
doxycycline.
OTHER INGREDIENTS
Sodium starch glycolate, maize starch, hydrogenated castor oil,
lactose
monohydrate, colloidal anhydrous silica, magnesium stearate, micro-
crystalline cellulose.
WHAT IS
_DOXY-DENK 100_
AND
WHAT IS IT USED FOR?
_Doxy-Denk 100_ is a broad-spectrum antibiotic and belongs to the
group
of antibiotics known as tetracyclines.
_DOXY-DENK 100_ is used in:
– Infections of the respiratory tract and ears, nose and throat:
– acute attacks of chronic bronchitis,
– infections of the nasal sinuses (sinusitis),
– tympanitis (otitis media),
– certain types of lung infections (pneumonia) caused by Mycoplas-
ma, Rickettsia or Chlamydia.
– Urogenital infections:
– inflammation of the urethra (urethritis) caused by Chlamydia and
Ureaplasma urealyticum,
– inflammation of the prostate gland (prostatitis),
– uncomplicated gonorrhoea (the clap, particularly in the presence
of Chlamydia infections),
– infections of the female sex organs,
– syphilis in patients who are allergic to penicillin,
– urinary tract infections (only if proven susceptibility of the
patho
-
gen).
– Gastrointestinal infections:
– cholera,
– infections caused by Campylobacter or Yersinia,
– Shigella infection with proven susceptibility.
– Outpatient therapy of infections of the biliary tract.
– Skin disease, including infected severe forms of common acne and
rosacea.
– Conjunctivitis (chlamydia conjunctivitis) a

Summary of Product characteristics

Trade name:
Generic name:
_Doxy-Denk 100 _
Doxycycline tablets 100 mg
1/ 14
S
UMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
_Doxy-Denk 100 _
Tablets – oral use
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient: doxycycline hyclate
1 tablet contains 115.4 mg doxycycline hyclate, equivalent to 100 mg
doxycycline.
Substance or indication group:
Broad-spectrum antibiotic
Doxycycline preparation
Doxycycline (alpha-6-desoxy-5-hydroxy-tetracycline) belongs to the
group of antibiotics
known as tetracyclines.
Other ingredients:
Sodium starch glycolate, maize starch, hydrogenated castor oil,
lactose monohydrate,
colloidal anhydrous silica, magnesium stearate, microcrystalline
cellulose.
3.
PHARMACEUTICAL FORM
Tablets
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Doxycycline in indicated for the treatment of infections caused by
pathogens that are
susceptible to doxycycline, particularly for the following:

Infections of the respiratory tract and ears, nose and throat:

acute attacks of chronic bronchitis,

sinusitis,

otitis media,

pneumonia caused by _Mycoplasma_, _Rickettsia_ or _Chlamydia_.

Urethral infections:

urethritis caused by _Chlamydia_ and _Ureaplasma urealyticum_,

acute prostatitis,

uncomplicated gonorrhoea (particularly in the presence of _Chlamydia_
infections),

infections of the female sex organs,

syphilis in patients who are allergic to penicillin,

urinary tract infections (only if proven susceptibility of the
pathogen).
Trade name:
Generic name:
_Doxy-Denk 100 _
Doxycycline tablets 100 mg
2/ 14

Gastrointestinal infections:

cholera,

infections caused by _Campylobacter_ or _Yersinia_

_Shigella_ infection with proven susceptibility.

Outpatient therapy of infections of the biliary tract.

Skin disease, including infected severe forms of common acne and
rosacea.

Clamydia conjunctivitis and trachoma caused by _Chlamydia_.

Illnesses caused by _Borrelia_, such as Erythema chronicum migrans und
Lyme d